Searchable abstracts of presentations at key conferences in endocrinology

ea0090p331 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Exploration of Clinical Improvements Following Setmelanotide in Patients With Bardet-Biedl Syndrome

Haqq Andrea M. , Chung Wendy , Dollfus Helene , Iqbal Anoop , A. Martos-Moreno Gabriel , Poitou Christine , Yanovski Jack A. , Malhotra Sonali , Miller Paul , Yuan Guojun , Forsythe Elizabeth , Clement Karine , Argente Jesus

Background: In patients with Bardet-Biedl syndrome (BBS), signaling impairments in the melanocortin-4 receptor (MC4R) pathway lead to hyperphagia and severe obesity, which negatively impact quality of life (QOL). We evaluated the impact of setmelanotide, an MC4R agonist, on age-appropriate weight-related parameters, hunger, and QOL in a Phase 3 trial of patients with BBS to further characterize clinical benefit in this patient population.Methods: Patient...

ea0090p124 | Endocrine-related Cancer | ECE2023

Exploring the interplay of RNA methylation and alternative splicing machineries in lung carcinoids

Pedraza Arevalo Sergio , Ibanez Costa Alejandro , Garcia Vioque Victor , Blazquez Encinas Rey Ricardo , Trinidad Moreno Montilla Maria , Agraz-Doblas Antonio , Foll Matthieu , Fernandez-Cuesta Lynnette , P. Castano Justo

Lung carcinoids are slow-proliferating neuroendocrine neoplasms commonly showing low mutational burden but a high heterogeneity and difficult clinical management. Despite valuable advances in their molecular characterization, some aspects remain still unknown. Recent studies have shown that alternative splicing is severely dysregulated in lung carcinoids, where it could promote tumoral features. In contrast, the role of some molecular systems closely related to splicing and ot...

ea0090p657 | Endocrine-related Cancer | ECE2023

Novel insights to study the potential of the somatostatin system in NETs and NECs

Mangili Federica , Trinidad Moreno Montilla Maria , Garcia Vioque Victor , Pedraza-Arevalo Sergio , Blazquez Encinas Rey Ricardo , Mantovani Giovanna , Peverelli Erika , Schrader Joerg , Ibanez Costa Alejandro , Castano Justo P.

Neuroendocrine tumors (NETs) and carcinomas (NECs) are a heterogeneous group of malignances whose incidence is increasing worldwide. First-line approach is represented by surgery, whereas an effective pharmacological treatment for disseminated and relapsing disease is still needed. Somatostatin (SS) receptors (SSTs) constitute the main suitable pharmacological targets for NETs therapy with SS analogs (SSAs). Nevertheless, a large proportion of NETs and most NECs, are unrespons...

ea0090ep151 | Calcium and Bone | ECE2023

Evaluation of the efficacy and safety of long-term Cinacalcet in primary hyperparathyroidism

Huguet Isabel , Timon Iciar Martin , Moreno-Ruiz Inmaculada , Yannuzzi Vanessa Trivino , Llavero Maria , Meizoso-Pita Olalla , Gargallo Fernandez Manuel Angel , Sevillano-Collantes Cristina

Introduction: Cinacalcet is a positive allosteric modulator of the calcium sensing receptor successfully used to decrease serum calcium in primary hyperparathyroidism (pHPT) patients in the short-term, but long-term data are scarce. In this single-centre retrospective analysis, we investigated the efficacy and safety of cinacalcet in pHPT patients who received more than 5 years of treatment.Methods: Statistical analysis was performed using free online so...

ea0090ep694 | Pituitary and Neuroendocrinology | ECE2023

Thyrotropin-secreting pituitary tumor: a rare entity

Torrecilla Pedro Jimenez , Gonzalez Lazaro Paloma , Moreno Tirado Antonio , Montero Benitez Maria Zhao , Lomas Meneses Amparo , Del Val Zaballos Florentino , Contreras Pascual Cristina

TSH-secreting pituitary adenomas are a rare cause of hyperthyroidism. The diagnosis should be considered in all hyperthyroid patients, especially those with a diffuse goiter and no extrathyroidal manifestations of GravesÂ’ disease. Most TSH-secreting adenomas secrete only TSH. Most patients have the typical symptoms and signs ofhyperthyroidism (eg, palpitations, tremor, heat intolerance), but a few patients have mild or even no hyperthyroid symptoms. Other clinical feature...

ea0090ep842 | Pituitary and Neuroendocrinology | ECE2023

Spontaneous involution of a cystic pituitary adenoma

Zhao Montero Benitez Maria , Gonzalez Lazaro Paloma , Moreno Tirado Antonio , Jimenez Torrecilla Pedro , Contreras Pascual Cristina , Del Val Zaballos Florentino , Lomas Meneses Amparo , Gomez Garcia Ines

Pituitary adenomas (PAs) account for 15-20% of intracranial tumors. PA with a cystic component are characterized in the MRI by a sellar, symmetrical, round or ovoid mass that enhances on T1- or T2-weighted images but does not concentrate gadolinium. We present the case of a 48-year-old man who in a headache study by Neurology requested a CT scan showing a cystic pituitary macroadenoma of 1.25cm confirmed by pituitary MRI. In the initial analysis, the pituitary function was pre...

ea0090ep1138 | Late Breaking | ECE2023

Clinical spectrum of ectopic Cushing’s syndrome secondary to pheochromocytoma: A diagnostic and therapeutic challenge

Gomes Porras Mariana , Kishore Doulatram Gamgaram Viyey , Gonzalez Molero Inmaculada , Gonzalez Romero Stella , Carmen Bautista Recio Maria , Cruz Almaraz Almaraz Maria , Moreno-Torres Taboada Carolina , Olveira Fuster Gabriel

Introduction: The clinical presentation of ectopic CushingÂ’s syndrome secondary to pheochromocytoma differs from the classic manifestations of these endocrinopathies separately. This cosecretion causes greater morbidity, requiring a complex preoperative preparation. We describe two clinical cases, a 46-year-old male with grade II overweight and a 65-year-old female with grade I obesity, both with a personal history of hypertension poorly controlled with 7 and 3 antihypert...

ea0063p369 | Thyroid 1 | ECE2019

Impact of thyroid autoimmunity on obstetric and perinatal outcomes in pregnant women with subclinical hypothyroidism

Oleaga Amelia , Jimenez-Telleria Patricia , Goni Fernando , Moreno Cristina , Arrizabalaga Cristina , Izuzquiza Ana , Espiga Javier , Martinez Adela , Zabalegui Alba , Paja Miguel

Introduction: Maternal clinical thyroid disorders can cause reproductive complications. However, the effects of mild thyroid dysfunction are controversial. The impact of SH and thyroid autoimmunity on miscarriages, obstetric and perinatal outcomes are not yet well established and the effect of levothyroxine replacement in pregnant women with SH is unclear. The aim of this study was to evaluate the impact of thyroid autoimmunity in early pregnancy on obstetric and perinatal out...

ea0063p405 | Thyroid 1 | ECE2019

Radiofrequency ablation in the treatment of benign thyroid nodules: a good alternative to surgery

Moreno Cristina , Paja Miguel , Izuzquiza Ana , Espiga Javier , Arrizabalaga Cristina , Martinez Adela Leyre , Monzon Andoni , Zabala Rosa , Iglesias Natalia , Calles Laura

Introduction: To date, benign thyroid nodules complainig of symptomatic or cosmetic problems and autonomous functioning thyroid nodules (AFTN) have generally been treated with surgery or I131. Radiofrequency ablation (RFA) is a novel technique that has demonstrated safety and efficacy in the treatment of these nodules. We describe the clinical experience at our hospital.Material and method: We include 33 patients (28 women, 5 men) from January 2013 to Se...

ea0063p547 | Diabetes, Obesity and Metabolism 2 | ECE2019

Clinical characteristics and foot amputations rate in patients treated in a multidisciplinary diabetic foot unit

Avila-Rubio Veronica , Lopez-Ibarra-Lozano Pablo J , Serrano-Laguna Carmen , Herrera-Mingorance Jose Damian , Moreno-Escobar Jose , Torres-Vela Elena

Objective: This study reviews the clinical characteristics of patients treated in a Multidisciplinary Diabetic Foot Unit (MDFU) and analyzes the rate of diabetic foot amputations and the risk factors associated.Design and methods: A retrospective cohort study including data from all patients who attended the MDFU during December 2017-October 2018 period. The patients were followed until January 2019. Clinical, anthropometric, and biochemical parameters (...